DcR2 Antikörper (Cy3)
Kurzübersicht für DcR2 Antikörper (Cy3) (ABIN733091)
Target
Alle DcR2 (TNFRSF10D) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human DcR2
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
FCM: 1:20-100, IF(IHC-P): 1:50-200
Optimal working dilution should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- DcR2 (TNFRSF10D) (Tumor Necrosis Factor Receptor Superfamily, Member 10d, Decoy with Truncated Death Domain (TNFRSF10D))
-
Andere Bezeichnung
- Dcr2/Tnfrsf10d
-
Hintergrund
- Optional[synonyms]: TNFRSF10D, Decoy receptor 2, CD 264, CD264, CD-264, DcR 2, decoy with truncated death domain, ID, TNF receptor related receptor for TRAIL, TNF related apoptosis inducing ligand receptor 4, TNFRSF 10D, TRAIL R4, TRAIL receptor 4, TRAIL receptor with a truncated death domain, TRAILR4, TRIALR 4, TRUNDD, Tumor necrosis factor receptor superfamily member 10d decoy with truncated death domain, Tumor necrosis factor receptor superfamily member 10D precursor, TR10D_HUMAN.
-
Gen-ID
- 8793
-
UniProt
- Q9UBN6
-
Pathways
- Apoptose
Target
-